Published in Brain on August 01, 2006
A diet-induced mouse model for glutaric aciduria type I. Brain (2006) 2.31
SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science (2005) 12.02
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
B(1) destructive interferences and spatial phase patterns at 7 T with a head transceiver array coil. Magn Reson Med (2005) 4.01
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Diabetic retinopathy: more than meets the eye. Surv Ophthalmol (2002) 2.95
The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci (2005) 2.83
Iron status and neural functioning. Annu Rev Nutr (2003) 2.63
Analysis of wave behavior in lossy dielectric samples at high field. Magn Reson Med (2002) 2.59
Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol (2004) 2.54
A diet-induced mouse model for glutaric aciduria type I. Brain (2006) 2.31
Diagnosis and management of glutaric aciduria type I--revised recommendations. J Inherit Metab Dis (2011) 2.14
Exploring the limits of RF shimming for high-field MRI of the human head. Magn Reson Med (2006) 2.11
Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care (2002) 2.04
Combination of optimized transmit arrays and some receive array reconstruction methods can yield homogeneous images at very high frequencies. Magn Reson Med (2005) 2.03
Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res (2006) 2.02
Temperature and SAR calculations for a human head within volume and surface coils at 64 and 300 MHz. J Magn Reson Imaging (2004) 2.01
Central brightening due to constructive interference with, without, and despite dielectric resonance. J Magn Reson Imaging (2005) 2.00
A perspective on errors, bias, and interpretation in the forensic sciences and direction for continuing advancement. J Forensic Sci (2009) 1.95
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
Oligodendrocytes and myelination: the role of iron. Glia (2009) 1.90
VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci (2006) 1.86
Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem (2009) 1.81
Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med (2006) 1.67
Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J Proteome Res (2006) 1.63
High-throughput zebrafish histology. Methods (2006) 1.62
TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes (2010) 1.60
Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain (2009) 1.59
Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes (2006) 1.58
Change in knee cartilage T2 at MR imaging after running: a feasibility study. Radiology (2004) 1.56
Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem (2002) 1.54
Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev Neurosci (2003) 1.51
Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO. Invest Ophthalmol Vis Sci (2013) 1.46
Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest Ophthalmol Vis Sci (2003) 1.45
Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis (2007) 1.44
Predicting phenotype from genotype: normal pigmentation. J Forensic Sci (2010) 1.43
Moderate iron deficiency in infancy: biology and behavior in young rats. Behav Brain Res (2006) 1.43
Measurement and correction of transmitter and receiver induced nonuniformities in vivo. Magn Reson Med (2005) 1.38
Factors influencing flip angle mapping in MRI: RF pulse shape, slice-select gradients, off-resonance excitation, and B0 inhomogeneities. Magn Reson Med (2006) 1.35
Manipulation of image intensity distribution at 7.0 T: passive RF shimming and focusing with dielectric materials. J Magn Reson Imaging (2006) 1.33
SAR and temperature: simulations and comparison to regulatory limits for MRI. J Magn Reson Imaging (2007) 1.32
Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS (2011) 1.32
Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci (2011) 1.32
Characterization of insulin signaling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab (2003) 1.29
Life spans and senescent phenotypes in two strains of Zebrafish (Danio rerio). Exp Gerontol (2002) 1.29
Age dependency of cartilage magnetic resonance imaging T2 relaxation times in asymptomatic women. Arthritis Rheum (2004) 1.28
Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta (2008) 1.24
Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics (2008) 1.23
A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency. Mol Genet Metab (2007) 1.23
Brain iron uptake and homeostatic mechanisms: an overview. Biometals (2003) 1.21
Functional magnetic resonance imaging study of human olfaction and normal aging. J Gerontol A Biol Sci Med Sci (2005) 1.21
The blood-retinal barrier: structure and functional significance. Methods Mol Biol (2011) 1.20
MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging (2009) 1.18
Numerical calculations of the static magnetic field in three-dimensional multi-tissue models of the human head. Magn Reson Imaging (2002) 1.18
Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J Neurosci Res (2002) 1.18
Polarization of the RF field in a human head at high field: a study with a quadrature surface coil at 7.0 T. Magn Reson Med (2002) 1.17
The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta (2013) 1.17
Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J Cereb Blood Flow Metab (2005) 1.17
Platelet-derived growth factor mediates tight junction redistribution and increases permeability in MDCK cells. J Cell Physiol (2002) 1.16
Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis. J Lipid Res (2004) 1.16
Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy. Curr Eye Res (2005) 1.15
Iron deficiency alters iron regulatory protein and iron transport protein expression in the perinatal rat brain. Pediatr Res (2003) 1.15
Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo. Diabetes (2012) 1.13
Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol (2004) 1.12
Zebrafish genomic instability mutants and cancer susceptibility. Genetics (2006) 1.12
Perinatal nutritional iron deficiency permanently impairs hippocampus-dependent trace fear conditioning in rats. Nutr Neurosci (2005) 1.12
Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal (2011) 1.11
Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke (2005) 1.10
Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci (2002) 1.10
Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem (2005) 1.09
Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve (2010) 1.09
Ornithine deficiency in the arginase double knockout mouse. Mol Genet Metab (2006) 1.08
Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol Cancer Ther (2006) 1.08
Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet (2002) 1.08
Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury. J Neuroinflammation (2013) 1.08
Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care (2014) 1.07
Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells. Neuropharmacology (2005) 1.07
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat (2013) 1.07
Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest (2007) 1.07
Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem (2008) 1.06
Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. J Proteome Res (2009) 1.05
Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model. Mol Cancer Ther (2009) 1.04